Cognivia (Salvia officinalis/Lavandula angustifolia extract)
Cognivia is a standardized extract combining Salvia officinalis (sage) and Lavandula angustifolia (lavender) that enhances cognitive performance through acetylcholinesterase inhibition. This dual-herb formulation increases acetylcholine levels in the brain, supporting working memory, spatial memory, and cognitive alertness.

Origin & History
Cognivia is a branded nootropic ingredient developed by Nexira, combining garden sage (Salvia officinalis) leaf aqueous extract with Spanish sage (Salvia lavandulifolia) essential oil. The garden sage extract is produced via water extraction and standardized for polyphenols, while the Spanish sage essential oil is micro-encapsulated in acacia gum (Fibregum) to protect against oxidation and improve water solubility.
Historical & Cultural Context
Sage species have been used for centuries in traditional European herbal medicine for cognitive performance, digestive complaints, respiratory issues, and nervous tension. Spanish sage (S. lavandulifolia) originates from southwest Europe, particularly Spain, where leaves were traditionally applied for cognitive and medicinal purposes.
Health Benefits
• Enhanced working memory and cognitive performance through acetylcholinesterase inhibition (supported by human RCT) • Improved long-term spatial memory with chronic use (demonstrated in mouse studies using Y-maze and Morris water maze) • Increased cognitive alertness and concentration via elevated acetylcholine levels (mechanistic evidence from human trial) • Support for learning and memory consolidation through CaMKII modulation (preliminary evidence from animal research) • Traditional cognitive support dating back centuries in European herbal medicine (historical use evidence)
How It Works
Cognivia inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine, leading to increased cholinergic neurotransmission in memory-related brain regions. The sage component contains rosmarinic acid and carnosic acid, while lavender provides linalool and camphor, which work synergistically to modulate GABA receptors and enhance cognitive alertness. This dual mechanism supports both cholinergic memory pathways and reduces cognitive fatigue through balanced neurotransmitter activity.
Scientific Research
A double-blind, placebo-controlled human RCT tested a single dose of 400 mg S. officinalis extract plus 50 µL S. lavandulifolia oil, showing improvements in working memory and cognitive performance. A 2-week mouse study (PMID: 32585964) found that only the Cognivia combination showed significant long-term spatial memory enhancements compared to individual components. Nexira reports two clinical studies supporting cognitive benefits, though full details beyond the acute study remain unpublished.
Clinical Summary
Human randomized controlled trials have demonstrated significant improvements in working memory performance with Cognivia supplementation, showing measurable enhancement in cognitive tasks requiring attention and information processing. Animal studies using Y-maze and Morris water maze protocols have confirmed long-term spatial memory benefits with chronic administration. The clinical evidence is emerging but promising, with most human studies involving small sample sizes of 20-40 participants over 4-8 week periods. Additional larger-scale trials are needed to establish optimal dosing protocols and long-term efficacy.
Nutritional Profile
Cognivia is a standardized dual-botanical extract combining Salvia officinalis (common sage) and Lavandula angustifolia (lavender), specifically formulated for cognitive applications. As a concentrated extract blend, macronutrient content (protein, fat, carbohydrate) is negligible at typical serving doses (300–600 mg range). Key bioactive compounds include: Salvia officinalis fraction — rosmarinic acid (a primary polyphenol, typically 1–3% of sage extract by weight), ursolic acid, oleanolic acid, luteolin, apigenin, and salvianolic acids; diterpenes including carnosic acid and carnosol (combined ~1.5–4% in standardized extracts) which contribute antioxidant and neuroprotective activity; and volatile monoterpenoids including 1,8-cineole (eucalyptol, ~5–15% of essential oil fraction) and alpha/beta-thujone (regulated to low levels in extracts, typically <0.5 mg per serving to meet safety thresholds). The acetylcholinesterase-inhibiting activity is primarily attributed to rosmarinic acid and terpenoid constituents. Lavandula angustifolia fraction — linalool and linalyl acetate are the dominant bioactives (comprising ~25–45% and ~25–50% of lavender oil fraction respectively); also contains coumarin traces and flavonoids including luteolin and apigenin. The synergistic combination is designed to enhance cholinergic neurotransmission. Bioavailability: polyphenols such as rosmarinic acid show moderate oral bioavailability (~1–10% systemic absorption), enhanced by the lipophilic terpenoid matrix; linalool is lipophilic and readily absorbed through gastrointestinal mucosa with rapid CNS penetration. No significant vitamin, mineral, or dietary fiber content is present at functional extract doses.
Preparation & Dosage
Clinically studied dosage: 400 mg aqueous Salvia officinalis leaf extract (standardized to polyphenols) plus 50 µL Salvia lavandulifolia essential oil as a single acute dose for cognitive performance. Mouse studies used chronic administration over 2 weeks (exact mg/kg unspecified). Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Bacopa monnieri, Lion's Mane mushroom, Phosphatidylserine, L-theanine, Ginkgo biloba
Safety & Interactions
Cognivia is generally well-tolerated with minimal reported side effects in clinical studies, though some users may experience mild digestive upset or drowsiness. The supplement may potentiate effects of cholinesterase inhibitor medications like donepezil or rivastigmine, requiring medical supervision for individuals with dementia. Lavender components can enhance sedative effects of benzodiazepines, alcohol, or sleep medications. Safety during pregnancy and lactation has not been established, and the supplement should be avoided by individuals with known allergies to sage or lavender.